September 25, 2016 1:57 AM ET

Biotechnology

Company Overview of Adaptimmune Therapeutics plc

Executive Profile

Adrian Rawcliffe

Chief Financial Officer, Adaptimmune Therapeutics plc
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships
44--

Background

Mr. Adrian Rawcliffe, also known as Ad, has been the Chief Financial Officer of Adaptimmune Therapeutics plc since March 16, 2015 and serves as its Principal Accounting Officer. Mr. Rawcliffe leads financial strategy, management and operations functions including compliance and risk management. He served as the Chief Financial Officer of Human Genome Sciences Inc. since August 2012. He has 17 years of experience within the pharmaceutical industry and also served as ...

Corporate Headquarters

101 Park Drive
Abingdon, Oxfordshire OX14 4RY

United Kingdom

Phone: 44 12 3543 0000
Fax: 44 12 3543 0001

Board Members Memberships

Director
Director
Director
Director
Director

Education

BS
Durham University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Unexercisable Options$3,600,000
Total Number of Options$3,600,000

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
$4.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adaptimmune Therapeutics plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.